Based on this, the research team proved that avasimibe, a small molecular inhibitor of sterol o-acyltransferase 1, had a good antitumor effect on patient-derived tumor tissue xenograft model of hepatocellular carcinoma, and provided new treatment strategies for tumor patients.7 Moreover, high-profile gene therapies also have to deliver the therapeutic genes into the cytoplasm or nucleus, where they can function. This evidence concerns the gene SOAT1 and neoplasm.